Pall Biotech

Novo Nordisk discovered how to optimize their mAb process

Find out how you can
save time and costs too

Single-pass TFF gave Novo Nordisk the potential to:

  • Reduce processing time
  • Reduce volume costs
  • Overcome storage limitations
  • Improve the final UF yield compared with conventional tangential flow filtration technology

Get the case study – and discover the benefits for you too!

Fill out the form
to download the article!

* Indicates required field